Sign in

CIK 0001360214

  • Large accelerated filer

HARROW, INC.

Sign in to watch
Ticker
HROW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450567010
Phone
+1 615-733-4731
Business address
1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
Former names
HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market sale 10% owner sold 30,204 shares at an average $30.59 ($923,827)
  7. 4 Open-market sale 10% owner sold 4,796 shares at an average $30.03 ($144,024)
  8. 4 Open-market sale 10% owner sold 15,000 shares at an average $26.13 ($391,904)
  9. 4/A Open-market sale 10% owner sold 5,000 shares at $29.64 ($148,200)
  10. 4/A Open-market sale 10% owner sold 5,000 shares at $30.01 ($150,055)
  11. 4 Shares withheld for taxes Chief Financial Officer gave up 136,745 shares (to pay taxes)
  12. 4 Shares withheld for taxes CEO & President, ImprimisRx gave up 109,475 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Executive Officer gave up 300,363 shares (to pay taxes)
  14. 4 Open-market sale 10% owner sold 5,000 shares at $30.01 ($150,055)
  15. 4 Open-market sale 10% owner sold 5,000 shares at $29.64 ($148,200)
  16. 4 Open-market sale 10% owner sold 5,000 shares at $28.05 ($140,250)
  17. 4 Open-market sale 10% owner sold 20,000 shares at $35.59 ($711,814)
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Shares withheld for taxes CEO of ImprimisRx gave up 45,140 shares (to pay taxes)

Page 2 of 15 · 296 filings